News | September 02, 2025
Zydus launches VaxiFlu vaccine for flu protection
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Nuvaxovid is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season
Guidelines aim to establish state-regulated veterinary blood banks
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Pfizer's vaccine helps protect against clinically relevant 20 serotypes responsible for a majority of invasive and non-invasive pneumococcal disease
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision
The new Zigly center features and offers comprehensive veterinary services
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
The Board of Directors of the company recommends a final dividend of Rs. 42 per equity share for the 12 months period ended March 31, 2025
Subscribe To Our Newsletter & Stay Updated
